Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 25,650 | 10,287 | 47,885 | 4,728 | 16,513 |
| Gross Profit | 25,650 | 10,287 | 47,885 | 4,728 | 16,513 |
| Operating Expenses | 76,575 | 68,118 | 67,197 | 62,237 | 59,896 |
| Operating Income | -50,925 | -57,831 | -19,312 | -57,509 | -43,383 |
| Interest Expense | 61 | 69 | 52 | 41 | 48 |
| Other Income | 8,924 | 9,343 | 4,996 | 4,683 | 4,632 |
| Pre-tax Income | -42,062 | -48,557 | -14,368 | -52,867 | -38,799 |
| Net Income Continuous | -42,062 | -48,557 | -14,368 | -52,867 | -38,799 |
| Net Income | $-42,062 | $-48,557 | $-14,368 | $-52,867 | $-38,799 |
| EPS Basic Total Ops | -0.58 | -0.69 | -0.25 | -0.90 | -0.67 |
| EPS Basic Continuous Ops | -0.58 | -0.69 | -0.24 | -0.90 | -0.67 |
| EPS Diluted Total Ops | -0.58 | -0.69 | -0.25 | -0.90 | -0.67 |
| EPS Diluted Continuous Ops | -0.58 | -0.69 | -0.24 | -0.90 | -0.67 |
| EPS Diluted Before Non-Recurring Items | -0.58 | -0.69 | -0.25 | N/A | N/A |
| EBITDA(a) | $-53,008 | $-59,442 | $-19,690 | $-57,831 | $-43,900 |